LGALS3 and systemic sclerosis: Various studies have reported increased GAL-3 serum levels in SSc patients compared to healthy subjects [21,47], although in contrast, another study reported that serum GAL-3 levels were significantly lower in patients with diffuse cutaneous SSc than in healthy subjects and limited cutaneous SSc [22].